UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Gray platelet syndrome: immunity goes awry

Blood, 2020-10, Vol.136 (17), p.1898-1900

2020

Volltextzugriff (PDF)

RUNX1/core binding factor A2 regulates platelet 12-lipoxygenase gene (ALOX12): studies in human RUNX1 haplodeficiency

Blood, 2010-04, Vol.115 (15), p.3128-3135

2010

Volltextzugriff (PDF)

Platelet disorders: the next generation is in

Blood, 2016-06, Vol.127 (23), p.2781-2782

2016

Volltextzugriff (PDF)

Inherited platelet dysfunction and hematopoietic transcription factor mutations

Platelets (Edinburgh), 2017-01, Vol.28 (1), p.20-26

2017

Volltextzugriff (PDF)

Editorial: Platelet Genomics and Disorders of Platelet Number and Function

Platelets (Edinburgh), 2017-01, Vol.28 (1), p.2-2

Rao, A. Koneti

2017

Volltextzugriff (PDF)

Regulation of platelet myosin light chain (MYL9) by RUNX1: implications for thrombocytopenia and platelet dysfunction in RUNX1 haplodeficiency

Blood, 2010-12, Vol.116 (26), p.6037-6045

2010

Volltextzugriff (PDF)

P2Y12 receptor inhibition and LPS-induced coagulation

Clinical science (1979), 2016-03, Vol.130 (6), p.441-442

2016

Volltextzugriff (PDF)

Effects of Hyperglycemia and Hyperinsulinemia on Circulating Tissue Factor Procoagulant Activity and Platelet CD40 Ligand

Diabetes (New York, N.Y.), 2006-01, Vol.55 (1), p.202-208

2006

Volltextzugriff (PDF)

Whole-Blood Tissue Factor Procoagulant Activity Is Elevated in Type 1 Diabetes: Effects of hyperglycemia and hyperinsulinemia

Diabetes care, 2012-06, Vol.35 (6), p.1322-1327

2012

Volltextzugriff (PDF)

Hematopoietic transcription factor mutations: important players in inherited platelet defects

Blood, 2017-05, Vol.129 (21), p.2873-2881

2017

Volltextzugriff (PDF)

Hematopoietic transcription factor mutations and inherited platelet dysfunction

F1000 prime reports, 2015-05, Vol.7, p.66-66

2015

Volltextzugriff (PDF)

Platelet protein kinase C-theta deficiency with human RUNX1 mutation: PRKCQ is a transcriptional target of RUNX1

Arteriosclerosis, thrombosis, and vascular biology, 2011-04, Vol.31 (4), p.921-927

2011

Volltextzugriff (PDF)

Circulating tissue factor procoagulant activity is elevated in stable moderate to severe chronic obstructive pulmonary disease

Thrombosis research, 2009-07, Vol.124 (3), p.259-261

2009

Volltextzugriff (PDF)

RUNX1 isoforms regulate RUNX1 and target genes differentially in platelets-megakaryocytes: association with clinical cardiovascular events

Journal of thrombosis and haemostasis, 2024-08

2024

Volltextzugriff (PDF)

Factor VIIa and tissue factor procoagulant activity in diabetes mellitus after acute ischemic stroke: impact of hyperglycemia

Thrombosis and haemostasis, 2007-11, Vol.98 (5), p.1007-1013

2007

Volltextzugriff (PDF)

Platelet microparticles infiltrating solid tumors transfer miRNAs that suppress tumor growth

Blood, 2017-08, Vol.130 (5), p.567-580

2017

Volltextzugriff (PDF)

A procoagulant state and endothelial dysfunction in obese children – response to Blann

British journal of haematology, 2013-03, Vol.160 (5), p.718-719

2013

Volltextzugriff (PDF)

Inherited platelet function disorders: overview and disorders of granules, secretion, and signal transduction

Hematology/oncology clinics of North America, 2013-06, Vol.27 (3), p.585-611

Rao, A Koneti

2013

Volltextzugriff (PDF)

Coagulation markers and functional outcome in acute ischemic stroke: Impact of intensive versus standard hyperglycemia control

Research and practice in thrombosis and haemostasis, 2021-07, Vol.5 (5), p.e12563-e12563, Article e12563

2021

Volltextzugriff (PDF)

Effect of antiplatelet agents clopidogrel, aspirin, and cilostazol on circulating tissue factor procoagulant activity in patients with peripheral arterial disease

Thrombosis and haemostasis, 2006-12, Vol.96 (6), p.738-743

2006

Volltextzugriff (PDF)

Platelet and monocyte activation by hyperglycemia and hyperinsulinemia in healthy subjects

Platelets (Edinburgh), 2006-12, Vol.17 (8), p.577-585

2006

Volltextzugriff (PDF)

Defective RAB1B-related megakaryocytic ER-to-Golgi transport in RUNX1 haplodeficiency: impact on von Willebrand factor

Blood advances, 2018-04, Vol.2 (7), p.797-806

2018

Volltextzugriff (PDF)

Cardiac Expression of Factor X Mediates Cardiac Hypertrophy and Fibrosis in Pressure Overload

JACC. Basic to translational science, 2020-01, Vol.5 (1), p.69-83

2020

Volltextzugriff (PDF)

Managing PAD with multiple platelet inhibitors: the effect of combination therapy on bleeding time

Journal of vascular surgery, 2003-10, Vol.38 (4), p.710-713

2003

Volltextzugriff (PDF)

Systems Pharmacogenomics Finds RUNX1 Is an Aspirin-Responsive Transcription Factor Linked to Cardiovascular Disease and Colon Cancer

EBioMedicine, 2016-09, Vol.11 (C), p.157-164

2016

Volltextzugriff (PDF)

1 – 25 von 447

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(400)
Mit Volltextzugriff
(381)

Publikationsform

Sprache

Englisch
(444)
Deutsch
(3)
Japanisch
(1)

Erscheinungsjahr

n.n

Thema

Science & Technology
(241)
Life Sciences & Biomedicine
(234)
Humans
(211)
Hematology
(104)
Biological And Medical Sciences
(99)
Male
(96)
Female
(92)
Cardiovascular System & Cardiology
(90)
Medical Sciences
(85)
Cardiac & Cardiovascular Systems
(56)
Adult
(52)
Hematologic And Hematopoietic Diseases
(47)
Child
(44)
Middle Aged
(41)
Peripheral Vascular Disease
(40)
Mutation
(38)
Immunology
(34)
Animals
(32)
Child, Preschool
(31)
Adolescent
(30)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)
... seit 90 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

Gray platelet syndrome: immunity goes awry

RUNX1/core binding factor A2 regulates platelet 12-lipoxygenase gene (ALOX12): studies in human RUNX1 haplodeficiency

Platelet disorders: the next generation is in

Inherited platelet dysfunction and hematopoietic transcription factor mutations

Editorial: Platelet Genomics and Disorders of Platelet Number and Function

Regulation of platelet myosin light chain (MYL9) by RUNX1: implications for thrombocytopenia and platelet dysfunction in RUNX1 haplodeficiency

P2Y12 receptor inhibition and LPS-induced coagulation

Effects of Hyperglycemia and Hyperinsulinemia on Circulating Tissue Factor Procoagulant Activity and Platelet CD40 Ligand

Whole-Blood Tissue Factor Procoagulant Activity Is Elevated in Type 1 Diabetes: Effects of hyperglycemia and hyperinsulinemia

Hematopoietic transcription factor mutations: important players in inherited platelet defects

Hematopoietic transcription factor mutations and inherited platelet dysfunction

Platelet protein kinase C-theta deficiency with human RUNX1 mutation: PRKCQ is a transcriptional target of RUNX1

Circulating tissue factor procoagulant activity is elevated in stable moderate to severe chronic obstructive pulmonary disease

RUNX1 isoforms regulate RUNX1 and target genes differentially in platelets-megakaryocytes: association with clinical cardiovascular events

Factor VIIa and tissue factor procoagulant activity in diabetes mellitus after acute ischemic stroke: impact of hyperglycemia

Platelet microparticles infiltrating solid tumors transfer miRNAs that suppress tumor growth

A procoagulant state and endothelial dysfunction in obese children – response to Blann

Inherited platelet function disorders: overview and disorders of granules, secretion, and signal transduction

Coagulation markers and functional outcome in acute ischemic stroke: Impact of intensive versus standard hyperglycemia control

Effect of antiplatelet agents clopidogrel, aspirin, and cilostazol on circulating tissue factor procoagulant activity in patients with peripheral arterial disease

Platelet and monocyte activation by hyperglycemia and hyperinsulinemia in healthy subjects

Defective RAB1B-related megakaryocytic ER-to-Golgi transport in RUNX1 haplodeficiency: impact on von Willebrand factor

Cardiac Expression of Factor X Mediates Cardiac Hypertrophy and Fibrosis in Pressure Overload

Managing PAD with multiple platelet inhibitors: the effect of combination therapy on bleeding time

Systems Pharmacogenomics Finds RUNX1 Is an Aspirin-Responsive Transcription Factor Linked to Cardiovascular Disease and Colon Cancer

Suchergebnisse filtern